Scientists have created a non-invasive, adhesive patch, which promises the measurement of glucose levels through the skin without a finger-prick blood test.
Scientists have created a non-invasive, adhesive patch, which promises the measurement of glucose levels through the skin without a finger-prick blood test, potentially removing the need for millions of diabetics to frequently carry out the painful and unpopular tests.
The patch does not pierce the skin, instead it draws glucose out from fluid between cells across hair follicles, which are individually accessed via an array of miniature sensors using a small electric current. The glucose collects in tiny reservoirs and is measured.
Readings can be taken every 10 to 15 minutes over several hours.
Crucially, because of the design of the array of sensors and reservoirs, the patch does not require calibration with a blood sample – meaning that finger prick blood tests are unnecessary.
Having established proof of the concept behind the device in a study published in Nature Nanotechnology, the research team from the University of Bath hopes that it can eventually become a low-cost, wearable sensor that sends regular, clinically relevant glucose measurements to the wearer’s phone or smartwatch wirelessly, alerting them when they may need to take action.
An important advantage of this device over others is that each miniature sensor of the array can operate on a small area over an individual hair follicle – this significantly reduces inter- and intra-skin variability in glucose extraction and increases the accuracy of the measurements taken such that calibration via a blood sample is not required.
Professor Richard Guy, from the Department of Pharmacy & Pharmacology, said: “A non-invasive – that is, needle-less – method to monitor blood sugar has proven a difficult goal to attain. The closest that has been achieved has required either at least a single-point calibration with a classic ‘finger-stick’, or the implantation of a pre-calibrated sensor via a single needle insertion. The monitor developed at Bath promises a truly calibration-free approach, an essential contribution in the fight to combat the ever-increasing global incidence of diabetes.”
Dr Adelina Ilie, from the Department of Physics, said: “The specific architecture of our array permits calibration-free operation, and it has the further benefit of allowing realisation with a variety of materials in combination. We utilised graphene as one of the components as it brings important advantages: specifically, it is strong, conductive, flexible, and potentially low-cost and environmentally friendly. In addition, our design can be implemented using high-throughput fabrication techniques like screen printing, which we hope will ultimately support a disposable, widely affordable device.”
In this study the team tested the patch on both pig skin, where they showed it could accurately track glucose levels across the range seen in diabetic human patients, and on healthy human volunteers, where again the patch was able to track blood sugar variations throughout the day.
The next steps include further refinement of the design of the patch to optimise the number of sensors in the array, to demonstrate full functionality over a 24-hour wear period, and to undertake a number of key clinical trials.
Learn more: Bloodless revolution in diabetes monitoring
The Latest on: Diabetes
via Google News
The Latest on: Diabetes
Researchers launch diabetes support program
on April 18, 2018 at 10:21 am
BHT program helps congregants at St. Margaret Mary Catholic Church and other churches in San Antonio. Credit: University of Texas at San Antonio Researchers at The University of Texas at San Antonio (UTSA) are taking diabetes education to church. […]
Leptin's neural circuit identified—Genome-editing study reveals how hormone helps prevent both obesity and diabetes
on April 18, 2018 at 10:01 am
An infrared thermal image of two mouse littermates following CRISPR-mediated genome editing of leptin signaling reveals surprises. Leptin, a fat hormone identified over 20 years ago, acts in the brain to maintain body weight and blood glucose balance ... […]
Class of type 2 diabetes drugs doesn't cut death risk compared to placebo
on April 18, 2018 at 9:24 am
April 18 (UPI) --In comparing three classes of medication for type 2 diabetes, researchers found one class, which includes the drugs Onglyza, Janumet and Januvia, did not reduce the risk of death. Scientists from Imperial College London found that ... […]
Two New Drug Classes Tied to Better Survival in Type 2 Diabetes
on April 18, 2018 at 8:31 am
Patients with type 2 diabetes who did not achieve adequate glycemic control with metformin had improved survival during follow-up if they received add-on therapy with a sodium-glucose cotransporter 2 (SGLT-2) inhibitor or a glucagon-like peptide 1 (GLP-1 ... […]
Type 2 diabetes: Late breakfast could drive obesity
on April 18, 2018 at 7:05 am
Going to bed later is linked with obesity in people with type 2 diabetes, and the main factor that drives this relationship is eating breakfast later. This was the conclusion of a new study now published in the journal Diabetic Medicine. The research was ... […]
Add Muscle Weakness as Another Cost of Type 1 Diabetes
on April 18, 2018 at 6:36 am
WEDNESDAY, April 18, 2018 (HealthDay News) -- Poor muscle health may be a complication of type 1 diabetes, even in young people who get plenty of exercise. That's the finding of Canadian researchers who analyzed muscle samples from young adults with and ... […]
How Big Data Is Fueling This Company's Digital War on Diabetes
on April 17, 2018 at 2:42 pm
Omada Health pulled of something that was, especially at the time, highly unusual in the ever-burgeoning yet still-fledgling digital health space: In 2016, the company scored federal government reimbursements for its diabetes prevention program. It’s ... […]
Gene affects how some women store fat -- and ups their diabetes risk
on April 17, 2018 at 11:14 am
Cruelly, the gene is sex specific: men with the same variation of the gene have a much less heightened diabetes risk. Cruelly, the gene is sex specific: Men with the same variation of the gene have a much less heightened diabetes risk. And some women with ... […]
BMI higher in type 2 diabetes patients who eat breakfast late: Study
on April 16, 2018 at 1:35 pm
April 16 (UPI) --Type 2 diabetics who prefer to stay up later at night and delay breakfast have a higher body mass, according to a study. Researchers studied whether morning or evening preference among people with type 2 diabetes was associated with an ... […]
via Bing News